28th Biennial Conference on Diseases of the Vulva and Vagina | Chicago, Illinois, USA.

Name: 28th Biennial Conference on Diseases of the Vulva and Vagina | Chicago, Illinois, USA.
Start: 2025-09-11T08:00:00-05:00
End: 2025-09-13T18:00:00-05:00
Location: Embassy Suites Chicago Downtown Magnificent Mile

Schedule

Thu, 11 Sep, 2025 at 08:00 am to Sat, 13 Sep, 2025 at 06:00 pm

UTC-05:00

Location

Embassy Suites Chicago Downtown Magnificent Mile | Chicago, IL

Join us in Chicago for the 28th Biennial Conference on Diseases of the Vulva and Vagina, a premier educational event dedicated to advancing clinical knowledge and research in vulvovaginal health.
Organized by the International Society for the Study of Vulvovaginal Disease (ISSVD), this two-day scientific program provides a unique opportunity for healthcare professionals from across disciplines to come together and learn from global experts. With over 450 expected attendees and more than 9 international speakers, this conference fosters professional growth, interdisciplinary collaboration, and evidence-based practice in the management of complex vulvovaginal conditions.
This event will cover a broad range of topics, including:
Lichen sclerosus, lichen planus, vulvodynia, and desquamative inflammatory vaginitis
Recurrent candidiasis and chronic bacterial vaginosis
Vulvar ulcers, dermatologic conditions, neoplasia, and pain syndromes
HPV-related disease and vulvar cancer pathways
Best practices in diagnostics, case-based learning, and clinical innovation
Attendees will benefit from over 30 scientific activities including:
Lectures
Case discussions
Hands-on workshops
Multidisciplinary panels
Opportunities for virtual engagement and enduring materials
Specialties represented include: Gynecology, Dermatology, Sexual Health Medicine, Oncology, Pathology, Pelvic Floor Physical Therapy, Nurse Practitioners, and Genito-Urinary Medicine.
Who Should Attend:
Medical professionals providing care for children, adolescents, and adults with vulvovaginal conditions—particularly those dealing with complex, persistent, or recurrent symptoms not resolved by common treatments.
Highlights:
Access to leading experts in vulvovaginal diseases
Multiformat learning opportunities
Networking with peers and key decision-makers
Complimentary virtual platform for registered participants
16,000+ outreach contacts through ISSVD network
Sponsorships: Jorge Quiroz, [email protected]